Terms: = Liver cancer AND ACVR1, SKR1, 90, ENSG00000115170, Q04771, ACVRLK2, FOP, ALK2, ACTRI AND Prognosis
1038 results:
1. Early detection of HCC in patients with cirrhosis using AI; a Systematic Review.
Khursheed AA; Khan MR
J Pak Med Assoc; 2024 Apr; 74(4 (Supple-4)):S29-S36. PubMed ID: 38712406
[TBL] [Abstract] [Full Text] [Related]
2. A retrospective clinical analysis of 11 cases of PEComa from different sites.
Yan J; Zhou D; Wang Y; Yang B; Wang Y; Zhang K; Zhang S; Zhang B; Meng Q; Lv Q
World J Surg Oncol; 2024 Apr; 22(1):116. PubMed ID: 38689335
[TBL] [Abstract] [Full Text] [Related]
3. Feasibility Study of Computed Tomographic Radiomics Model for the Prediction of Early and Intermediate Stage Hepatocellular Carcinoma Using BCLC Staging.
Dong H; Yang L; Shaofeng D; Lili G
Technol Cancer Res Treat; 2024; 23():15330338241245943. PubMed ID: 38660703
[TBL] [Abstract] [Full Text] [Related]
4. A hypoxia-glycolysis-lactate-related gene signature for prognosis prediction in hepatocellular carcinoma.
Qin X; Sun H; Hu S; Pan Y; Wang S
BMC Med Genomics; 2024 Apr; 17(1):88. PubMed ID: 38627714
[TBL] [Abstract] [Full Text] [Related]
5. Multiscale and multiperception feature learning for pancreatic lesion detection based on noncontrast CT.
Yan T; Tang G; Zhang H; Liang L; Ma J; Gao Y; Zhou C; Li S
Phys Med Biol; 2024 May; 69(10):. PubMed ID: 38588676
[No Abstract] [Full Text] [Related]
6. UBE2C: A pan-cancer diagnostic and prognostic biomarker revealed through bioinformatics analysis.
Jalali P; Samii A; Rezaee M; Shahmoradi A; Pashizeh F; Salehi Z
Cancer Rep (Hoboken); 2024 Apr; 7(4):e2032. PubMed ID: 38577722
[TBL] [Abstract] [Full Text] [Related]
7. Metformin and pancreatic neuroendocrine tumors: A systematic review and meta-analysis.
Cigrovski Berkovic M; Coppola A; Sesa V; Mrzljak A; Lai Q
World J Gastroenterol; 2024 Feb; 30(7):759-769. PubMed ID: 38515954
[TBL] [Abstract] [Full Text] [Related]
8. An integrative pan-cancer analysis of the molecular characteristics of dietary restriction in tumour microenvironment.
Song X; Wei J; Li Y; Zhu W; Cai Z; Li K; Wei J; Lu J; Pan W; Li M
EBioMedicine; 2024 Apr; 102():105078. PubMed ID: 38507875
[TBL] [Abstract] [Full Text] [Related]
9. Development of a Serum-Based MicroRNA Signature for Early Detection of Pancreatic cancer: A Multicenter Cohort Study.
Huang J; Gao G; Ge Y; Liu J; Cui H; Zheng R; Wang J; Wang S; Go VL; Hu S; Liu Y; Yang M; Sun Y; Shang D; Tian Y; Zhang Z; Xiang Z; Wang H; Guo J; Xiao GG
Dig Dis Sci; 2024 Apr; 69(4):1263-1273. PubMed ID: 38451429
[TBL] [Abstract] [Full Text] [Related]
10. The role of baseline 2-[
Albano D; Calabrò A; Dondi F; Bagnasco S; Tucci A; Bertagna F
Hematol Oncol; 2024 Mar; 42(2):e3266. PubMed ID: 38444261
[TBL] [Abstract] [Full Text] [Related]
11. Circulating miRNA's biomarkers for early detection of hepatocellular carcinoma in Egyptian patients based on machine learning algorithms.
Sayed GI; Solyman M; El Gedawy G; Moemen YS; Aboul-Ella H; Hassanien AE
Sci Rep; 2024 Feb; 14(1):4989. PubMed ID: 38424116
[TBL] [Abstract] [Full Text] [Related]
12. Effect of Behavioral Health Disorders on Surgical Outcomes in cancer Patients.
Katayama ES; Woldesenbet S; Munir MM; Endo Y; Rawicz-Pruszyński K; Khan MMM; Tsilimigras D; Dillhoff M; Cloyd J; Pawlik TM
J Am Coll Surg; 2024 Apr; 238(4):625-633. PubMed ID: 38420963
[TBL] [Abstract] [Full Text] [Related]
13. A Systematic Review and Meta-Analysis of MRI Radiomics for Predicting Microvascular Invasion in Patients with Hepatocellular Carcinoma.
Zhou HY; Cheng JM; Chen TW; Zhang XM; Ou J; Cao JM; Li HJ
Curr Med Imaging; 2024; 20():1-11. PubMed ID: 38389371
[TBL] [Abstract] [Full Text] [Related]
14. USP21 deubiquitinates and stabilizes HSP90 and ENO1 to promote aerobic glycolysis and proliferation in cholangiocarcinoma.
Xu X; Chen Y; Shao S; Wang J; Shan J; Wang Y; Wang Y; Chang J; Zhou T; Chen R; Liu S; Li C; Li C; Li X
Int J Biol Sci; 2024; 20(4):1492-1508. PubMed ID: 38385089
[TBL] [Abstract] [Full Text] [Related]
15. The Role of TGF-β/SMAD Signaling in Hepatocellular Carcinoma: from Mechanism to Therapy and prognosis.
Xin X; Cheng X; Zeng F; Xu Q; Hou L
Int J Biol Sci; 2024; 20(4):1436-1451. PubMed ID: 38385079
[TBL] [Abstract] [Full Text] [Related]
16. miR-557 inhibits hepatocellular carcinoma progression through Wnt/β-catenin signaling pathway by targeting RAB10.
Cheng X; Wu C; Xu H; Zou R; Li T; Ye S
Aging (Albany NY); 2024 Feb; 16(4):3716-3733. PubMed ID: 38364252
[TBL] [Abstract] [Full Text] [Related]
17. A Pilot Study of Pembrolizumab in Combination With Y90 Radioembolization in Subjects With Poor prognosis Hepatocellular Carcinoma.
Yu S; Yu M; Keane B; Mauro DM; Helft PR; Harris WP; Sanoff HK; Johnson MS; O'Neil B; McRee AJ; Somasundaram A
Oncologist; 2024 Mar; 29(3):270-e413. PubMed ID: 38325328
[TBL] [Abstract] [Full Text] [Related]
18. Nomograms confirm serum IL-6 and CRP as predictors of immune checkpoint inhibitor efficacy in unresectable hepatocellular carcinoma.
Du J; Huang Z; Zhang E
Front Immunol; 2024; 15():1329634. PubMed ID: 38304429
[TBL] [Abstract] [Full Text] [Related]
19. [A Case of Cecal cancer Diagnosed from Sister Mary Joseph's Nodule].
Miyazaki Y; Morimoto Y; Hashimoto Y; Michiura T; Hayashi N; Yamabe K
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1828-1830. PubMed ID: 38303221
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic significance of cyclin-dependent kinase subunit 2 (CKS2) in malignant tumours: a meta-analysis and bioinformatic analysis.
Zhang Y; Li Z; Huang Y; Zou B; Xu Y
BMJ Open; 2024 Jan; 14(1):e073887. PubMed ID: 38296306
[TBL] [Abstract] [Full Text] [Related]
[Next]
